Leveron&Nexovas
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 6773  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  » Next article
  » Previous article 
  » Table of Contents
  
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
  »  Article in PDF (1,267 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  

 
  In this Article
 »  Abstract
 »  Introduction
 »  Patients and Methods
 »  Results
 »  Discussion
 »  References
 »  Article Figures
 »  Article Tables

 Article Access Statistics
    Viewed6375    
    Printed221    
    Emailed1    
    PDF Downloaded132    
    Comments [Add]    
    Cited by others 3    

Recommend this journal

 


 
ORIGINAL ARTICLE
Year : 2010  |  Volume : 58  |  Issue : 5  |  Page : 685-690

A new method to classify pathologic grades of astrocytomas based on magnetic resonance imaging appearances


1 Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu Sichuan - 610 041, P.R., China
2 Department of Neurosurgery, West China School of Medicine, Sichuan University, Chengdu Sichuan - 610 041, P.R., China
3 Department of Radiology, West China Hospital, Sichuan University, Chengdu Sichuan - 610 041, P.R., China

Date of Acceptance24-Jun-2010
Date of Web Publication28-Oct-2010

Correspondence Address:
Min He
Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu Sichuan - 610 041, P.R.
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.72161

Rights and Permissions

 » Abstract 

Background: Astrocytoma is the most common neuroepithelial neoplasm, and its grading greatly affects treatment and prognosis. Objective: According to relevant factors of astrocytoma, this study developed a support vector machine (SVM) model to predict the astrocytoma grades and compared the SVM prediction with the clinician's diagnostic performance. Patients and Methods: Patients were recruited from a cohort of astrocytoma patients in our hospital between January 2008 and April 2009. Among all astrocytoma patients, nine had grade I, 25 had grade II, 12 had grade III, and 60 had grade IV astrocytoma. An SVM model was constructed using radial basis kernel. The SVM model was trained with nine magnetic resonance (MR) features and one clinical parameter by fivefold cross-validation and differentiated astrocytomas of grades I-IV at two levels, respectively. The clinician also predicted the grade of astrocytoma. According to the two prediction methods above, the areas under receiving operating characteristics (ROC) curves to discriminate low- and high-grade groups, accuracies of high-grade grouping, overall accuracy, and overall kappa values were compared. Results: For SVM, the overall accuracy was 0.821 and the overall kappa value was 0.679; for clinicians, the overall accuracy was 0.651 and the overall kappa value was 0.466. The diagnostic performance of SVM is significantly better than clinician performance, with the exception of the low-grade group. Conclusions: The SVM model can provide useful information to help clinicians improve diagnostic performance when predicting astrocytoma grade based on MR images.


Keywords: Astrocytoma, magnetic resonance imaging, pathology, support vector machine


How to cite this article:
Zhao ZX, Lan K, Xiao JH, Zhang Y, Xu P, Jia L, He M. A new method to classify pathologic grades of astrocytomas based on magnetic resonance imaging appearances. Neurol India 2010;58:685-90

How to cite this URL:
Zhao ZX, Lan K, Xiao JH, Zhang Y, Xu P, Jia L, He M. A new method to classify pathologic grades of astrocytomas based on magnetic resonance imaging appearances. Neurol India [serial online] 2010 [cited 2022 Aug 15];58:685-90. Available from: https://www.neurologyindia.com/text.asp?2010/58/5/685/72161



 » Introduction Top


Astrocytomas are one of the most lethal and difficult to treat tumors among neuroepithelial neoplasms. [1] According to the 2007 World Health Organization (WHO) classification of tumors of the central nervous system, astrocytomas can be classified into grades I-IV. [2] Because exact grading was obtained by pathologists through examining tissue section slides, and malignancy grading of astrocytomas is fundamentally important due to its effects on accurate treatment planning and patient management, it is important to assess tumor grading before operation. [1],[3],[4],[5],[6]

Today, pre-operative tumor grade prediction generally depends on imaging techniques such as magnetic resonance imaging (MRI), which is used to locate the position and extent of brain tumors. [7] Additionally, studies have shown that the MRI characteristics from astrocytomas of different grades have been documented in the radiologic literature, and the accuracy of access is dependent on edema, hemorrhage, cyst, and so on. [8],[9],[10] However, tumor staging is subjective, and its accuracy may be limited by the radiologist's experience. Therefore, we consider the application of some auxiliary methods, with the aim of improving the prediction of tumor grades. Support vector machine (SVM) modeling is a novel and useful classification method. As a cutting-edge algorithm, it maps input vector current space to higher dimensional space, and a separating hyperplane is found that transforms the set of data into linearly separable data. Recent researches have reported that SVM has a good performance. [10],[11],[12],[13],[14],[15] In this study, SVM was applied and compared with the predictions of clinical observers to determine whether SVM can help to predict astrocytoma grades.


 » Patients and Methods Top


Case selection

In this study, patients were recruited from a cohort of astrocytoma patients in our hospital, between January 2008 and April 2009. Patients had to satisfy the following inclusion criteria: 1) new diagnosis of astrocytoma at our hospital; 2) clear pathologic grading (grades I-IV); and 3) complete pre-contrast T1-weighted images (T1WIs), T2-weighted images (T2WIs), and post-contrast T1WIs. Cases were excluded if their grades were overlapping, or if they had received previous radiation therapy.

Database

All astrocytoma patients were classified into four groups (WHO grades I-IV) according to the 2007 WHO classification of tumors of the central nervous system. In all patients, MRI was conducted with a 1.5-Tesla unit (TOSHIBA, Tokyo, Japan) and a 3.0-Tesla unit (GE Medical Systems, Milwaukee, WI, USA). For every recruited patient, pre-contrast and post-contrast T1WIs (TR, 380-523 ms; TE, 7-26 ms) and pre-contrast T2WIs (TR, 3500-5659 ms; TE, 82-113 ms) were collected. Other MRI parameters were set to a 256 Χ 192 or 256 matrix, a 200 Χ 230-mm field of view (FOV), and a 5-mm slice thickness. Gadopentate dimeglumine (Magnevist, Berlex, Cedar Knolls, New Jersey) at 0.1 mmol/kg body weight was administered intravenously for post-contrast MRI.

As described in [Figure 1], a neuroradiologist without the knowledge of pathologic results reviewed the images independently and scored 10 parameters: one clinical parameter (age) and nine MRI characteristics (signal intensity on T1W imaging, signal intensity on T2W imaging, contrast enhancement, edema, location, heterogeneity, border definition, cyst formation, mass effect) [Table 1].
Figure 1: MR images of a 70-year-old man with glioblastoma confirmed on pathologic examination (WHO grade IV). T2WI on the left shows a heterogeneously hyperintense mass with surrounding intense signal abnormality referred to as marked edema. Pre-contrast T1WI in the middle and post-contrast T1WI on the right show marked ring enhancement

Click here to view
Table 1: Parameters of MR images of 106 patients with distribution of their ratings

Click here to view


Design of the classification scheme

As shown in [Figure 2], a hierarchical tree classification scheme was designed to discriminate among astrocytoma grades I through IV. At the first level, the astrocytomas were grouped into two parts: low-grade (grades I to II) and high-grade (grades III to IV). At the second level, we discriminated between the individual grades.
Figure 2: Hierarchical tree classification scheme and items of comparison of astrocytoma grades I-IV

Click here to view


At each level, classification was done using two methods based on the score. The first method was the cooperative prediction from clinical observers: a fully experienced neuroradiologist and neurosurgeon. The neurosurgeon analyzed the clinical feature to help the radiologist to read images in predicting the grades. The second method was the SVM-based grade prediction. At the first level, when astrocytomas were classified into low-grade and high-grade groups, receiving operating characteristics (ROC) curves were employed to demonstrate and compare the performance between two methods. We defined two classification results: SVM output (1, −1) and observers' conclusion (high-grade marked with 1 and low-grade marked with −1) as an actual positive result if the prediction was correct and as an actual negative result if the prediction was wrong. Accordingly, true pathologic grade score and prediction score fit a nonparametric ROC curve. Observers and the SVM model demonstrated two ROC curves to discriminate the classification of the first level by the areas under ROC curves. At the second level, low-grade and high-grade groups' accuracies were calculated from two methods, and the results of the two methods were compared for each group. Finally, according to the results of the second level, the overall accuracy and kappa values of two methods can be obtained and compared.

Development of support vector machine model

The theory of SVM is as follows. In brief, given a training set, where xi are observations, and yi are corresponding labels (e.g., −1 for low-grade, +1 for high-grade), [16],[17] the following quadratic optimization problem is solved:



where C is the constant, and ξ are positive slack variables allowing some examples to lie on the wrong side of the soft margin. Here, training vectors are mapped into a higher dimensional space by the φ function. Furthermore, K(xi, xj) is the kernel function. In this study, the kernel function was set to the radial basis function:



Therefore, the SVM model is defined by parameters C and γ. In this research, they were found by a "grid-search" using fivefold cross-validation. In fivefold cross-validation, the training is set into five subsets of equal size; when one subset is designated as the test set, the others comprise the training set; each subset is designated as the test set in turn. The "grid-search" tries every combination of (C, γ) with values ranging from C = 2-5 … 215 to γ = 2-15… 23, and receptively computes the accuracy and finds the combination of (C, γ) with maximum accuracy. At the first level, all the data are set to input vectors to determine the best C and γ, but at the second level we use the right grade to search for C and γ. For example, for the low-grade group, after prediction of the first level, the data with grade III to IV were excluded from training set. When the suitable combination of (C, γ) was found, the SVM model was applied to predict the whole low-grade group, including the data for grade III to IV above. In this way, three different (C, γ) values can be calculated.

Data processing and statistical analysis

To develop the SVM model, the libsvm tools version 2.9 based on Python was implied. [18] The Bowker test (i.e., generalized McNemar test) and kappa value for overall accuracy were computed by using PASW Statistics 18.0.0. [19] Other statistical analysis was conducted using Stata11.0 (MP edition). For all comparisons, a two-tailed statistical significance level was set at P < 0.05.


 » Results Top


A total of 106 patients with astrocytoma (39 males and 67 females; median age 43 years; age range 2-77 years) met the inclusion/exclusion criteria. Among all the patients, the grades ranged from grades I to IV: n = 9 grade I, n = 25 grade II, n = 12 grade III, and n = 60 grade IV cases. The distribution of patients' scores is summarized in [Table 1].

After development and training of the SVM model, there were three different (C, γ) parameters - (3, −5), (9, −13) and (3, −5) - to three corresponding SVM models at different levels of the scheme. The models were assessed separately for the whole data set, the subset comprising grades I and II, and the subset comprising grades III and IV.

After the whole data with grades I-IV were divided into low-grade and high-grade groups by two methods, the areas under the ROC curves (AUCs) can be respectively computed for comparison. As shown in [Figure 3], the areas of two methods were both above 0.5 due to the lower limit of each confidence interval upon 0.5. Furthermore, as given in [Table 2], the AUC of the SVM was significantly greater than that of the observers (P = 0.004). In the following comparison, although the accuracies of two methods in the low-grade group were not the same, the result is not statistically significant (P = 0.092). However, the accuracies of the two methods in the high-grade group were 0.846 and 0.662 (P = 0.008). Finally, in general comparison, the overall accuracies and kappa values were calculated. The accuracy of SVM differed significantly from the accuracy of the observers (P = 0.001); the kappa values of SVM and observers were 0.679 (P < 0.001) and 0.466 (P < 0.001), respectively.
Figure 3: A comparison of ROC curves between SVM and observers to discriminate low- and high-grade astrocytomas. Numbers in the legend show the AUCs and corresponding confidence intervals

Click here to view
Table 2: Comparison of predictions by two methods

Click here to view



 » Discussion Top


Grading of astrocytomas is an important task because it affects treatment planning and is of prognostic importance. [2] In this study, nine MR features and one clinical parameter were extracted and merged to analyze and predict astrocytoma grades. The results demonstrated satisfactory performance of the SVM model, indicating that the SVM model can merge a large amount of information based on one clinical parameter and MR features and find the hyperplane through computation to accurately discriminate among the range astrocytoma grades.

In this research, MR features (e.g., enhancement, edema, cyst formation) were selected because prior research has verified that astrocytoma grading is dependent on the association of MR features. [8],[9],[20],[21],[22],[23] Among the selected MR features, edema and enhancement were most important to discriminate the pathologic grade of astrocytoma.[24],[25] In addition, apparent diffusion coefficient (ADC) values were affected by the change from encephalic cyst, necrosis, hemorrhage, and air of skull base bone or sinus, and the change of ADC affected other types MR such as perfusion-weight images (PWIs), diffusion-weight images (DWIs), MR spectroscopy, and fluid-attenuated inversion-recovery images. Although susceptibility-weighted imaging is very sensitive regarding tumor hemorrhage and venous structure, there was no clear conclusion regarding whether susceptibility-weighted imaging would provide better demonstration of the tumor edema and boundary than conventional MR. [26],[27] Therefore, in this study, only T1WI (pre- and post-contrast) and T2WI were selected. [28],[29]

A previous study showed that radiologists were able to discriminate low-grade and high-grade astrocytomas with an accuracy of 0.806 (29/36). [20] In this study, observers correctly classified 81 cases of 106 astrocytomas at the first level, resulting in an accuracy of 0.764 (81/106), in accordance with the prior study (χ2 = 0.264, P = 0.607). This demonstrated that ability of observers to predict astrocytoma grade in this study was credible.

The MR diagnosis of astrocytomas was usually made subjectively. Therefore, an auxiliary computerized scheme capable of providing objective information was applied to discriminate the grades of astrocytomas. [20],[22],[30] Most computerized schemes only elaborated the discrimination of low-grade and high-grade astrocytomas rather than grades I-IV. In this study, we used two level classification to individually discriminate grades I-IV. This type of hierarchical tree classification scheme was preferred because it was similar with the diagnostic procedure: initially, astrocytomas were separated into low-grade and high-grade groups, and subsequently separated into each individual grade. This hierarchical tree classification scheme had also given good results in similar researches conducted earlier. [31],[32],[33]

According to the parameters selected as described above, the prediction is shown in [Table 2]. Every diagnostic performance of the SVM model was better in terms of accuracy than the observers' predictions, but the difference in predictive accuracy between the two methods had no statistical significance in the low-grade group. At the first level, ROC was applied to evaluate and compare SVM and observer methods. This is because for the binary classification problem, ROC analysis has proven very useful for evaluating the two-class classifier. [34] The AUCs differ significantly between SVM and the clinical observers (P = 0.004). This indicates that the SVM can provide information to help clinicians discriminate between low-grade and high-grade astrocytomas. At the second level, the accuracies of only two methods were compared because it was not certain that there were two or more categories of grade. There was no significant difference between methods in the low-grade group (P = 0.092). A larger sample size might reduce the P value and improve the precision of SVM-based prediction.

In the high-grade group, as a result of the significantly different accuracies of the two methods (P = 0.008), SVM can be used to help clinicians to distinguish between grade III and grade IV astrocytomas. For the overall grading, we compared the accuracies using the Bowker test, as it is suitable to the multi-class classification paired problem. [19] The result demonstrated that the overall accuracies differed significantly between the two methods. Overall, SVM may be particularly helpful for readers with limited clinical experience.

In conclusion, as a classification model, SVM has demonstrated the ability to discriminate astrocytoma grades I through IV and can improve the diagnostic performance of clinicians in staging astrocytomas.

 
 » References Top

1.DeAngelis LM. Brain tumors. N Engl J Med 2001;344:114-23.  Back to cited text no. 1
[PUBMED]  [FULLTEXT]  
2.Louis DN, Ohgaki H,Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007WHO classification of tumours of the central nervous system. Acta Neuropathol (Berl) 2007;114:97-109.  Back to cited text no. 2
    
3.Hutter A, Schwetye KE, Bierhals AJ, McKinstry RC. Brain neoplasms: epidemiology, diagnosis, and prospects for cost-effective imaging. Neuroimaging Clin N Am 2003;13:237-50.  Back to cited text no. 3
[PUBMED]    
4.Bampoe J, Bernstein M. The role of surgery in low grade gliomas. J Neuro Oncol 1999;42:259-69.  Back to cited text no. 4
    
5.Claus EB, Black PM. Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001. Cancer 2006;106;1358-63.  Back to cited text no. 5
    
6.Law M, Oh S, Babb JS, Wang E, Inqlese M, Zaqzaq D, et al. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging-prediction of patient clinical response. Radiology 2006;238:658-67.  Back to cited text no. 6
    
7.Madison MT, Hall WA, Latchaw RE, Loes DJ. Radiologic diagnosis, staging, and follow-up of adult central nervous system primary malignant glioma. Radiol Clin North Am 1994;32:183-96.  Back to cited text no. 7
[PUBMED]    
8.Mihara F, Numaguchi Y, Rothman M, Sato S, Fiandaca M. MR imaging of adult supratentorial astrocytomas: an attempt of semi-automatic grading. Radiat Med 1995;13:5-9.  Back to cited text no. 8
    
9.Mihara F, Numaguchi Y, Rothman M, Kristt D, Fiandaca M, Swallow L. Non-enhancing supratentorial malignant astmcytomas: MR features and possible mechanisms. Radiat Med 1995;13:11-7.  Back to cited text no. 9
[PUBMED]    
10.Li GZ, Yang J, Ye CZ, Geng DY. Degree prediction of malignancy in brain glioma using support vector machines. Comput Biol Med 2006;36:313-25.  Back to cited text no. 10
[PUBMED]  [FULLTEXT]  
11.Herlidou-Meme S, Constans JM, Carsin B, Olivie D, Eliat PA, Nadal-Desbarats L, et al. MRI texture analysis on texture test objects, normal brain and intracranial tumors. Magn Reson Imaging 2003;21:989-93.  Back to cited text no. 11
    
12.Devos A, Simonetti AW, van der Graaf M, Lukas L, Suykens JA, Vanhamme L, et al. The use of multivariate MR imaging intensities versus metabolic data from MR spectroscopic imaging for brain tumour classification. J Magn Reson 2005;173;218-28.  Back to cited text no. 12
    
13.Georqiadis P, Cavouras D, Kalatzis I, Daskalakis A, Kaqadis GC, Sifaki K, et al. Improving brain tumor characterization on MRI by probabilistic neural networks and non-linear transformation of textural features. Comput Methods Programs Biomed 2008;89:24-32.  Back to cited text no. 13
    
14.Gerardin E, Chιtelat G, Chupin M, Cuingnet R, Desgranges B, Kim HS, et al. Multidimensional classification of hippocampal shape features discriminates Alzheimer′s disease and mild cognitive impairment from normal aging. Neuroimage 2009;47:1476-86.  Back to cited text no. 14
    
15.Wang Z. A hybrid SVM-GLM approach for fMRI data analysis. Neuroimage 2009;46:608-15.  Back to cited text no. 15
[PUBMED]  [FULLTEXT]  
16.Vapnik V. The Nature of Statistical Learning Theory. New York: Springer; 1995.  Back to cited text no. 16
    
17.Vapnik V. Statistical Learning Theory. New York: John Wiley and Sons; 1998.  Back to cited text no. 17
    
18.Chang CC, Lin CJ. LIBSVM: a library for support vector machines. 2001. Available from: http://www.csie.ntu.edu.tw/~cjlin/libsvm. [last cited on 2009 Oct 20].  Back to cited text no. 18
    
19.Bowker AHA test for symmetry in contingency tables. Amer Statist Assoc 1948;43:572-4.  Back to cited text no. 19
    
20.Abdolmaleki P, Mihara F, Masuda K, Buadu LD. Neural networks analysis of astrocytic gliomas from MRI appearances. Cancer Lett 1997;118:69-78.  Back to cited text no. 20
[PUBMED]    
21.Galanaud D, Nicoli F, Chinot O, Confort-Gouny S, Figarella-Branger D, Roche P, et al. Noninvasive diagnostic assessment of brain tumors using combined in vivo MR imaging and spectroscopy. Magn Reson Med 2006;55:1236-45.  Back to cited text no. 21
[PUBMED]  [FULLTEXT]  
22.Yamashita K, Yoshiura T, Arimura H, Minhara F, Noguchi T, Hiwatashi A, et al. Performance evaluation of radiologists with artificial neural network for differential diagnosis of intra-axial cerebral tumors on MR images. AJNR Am J Neuroradiol 2008;29:1153-8.  Back to cited text no. 22
    
23.Emblem KE, Nedregaard B, Hald JK, Nome T, Due-Tonnessen P, Bjornerud A. Automatic glioma characterization from dynamic susceptibility contrast imaging: brain tumor segmentation using knowledge-based fuzzy clustering. J Magn Reson Imaging 2009;30: 1-10.  Back to cited text no. 23
[PUBMED]  [FULLTEXT]  
24.Tervonen O, Forbes G, Scheithauer BW, Dietz MJ. Diffuse "fibrillary" astrocytomas: correlation of MRI features with histopathologic parameters and tumor grade. Neuroradiology 1992;34:173-8.  Back to cited text no. 24
[PUBMED]    
25.Aronen HJ, Glass J, Pardo FS, Belliveau JW, Gruber ML, Buchbinder BR, et al. Echo-planar MR cerebral blood volume mapping of gliomas. Clinical utility. Acta Radiol 1995;36:520-8.  Back to cited text no. 25
[PUBMED]    
26.Haddar D, Haacke E, Sehgal V, Delproposto Z, Salamon G, Seror O, et al. Susceptibility-weighted imaging. Theory and applications. J Radiol 2004;85:1901-8.  Back to cited text no. 26
[PUBMED]  [FULLTEXT]  
27.Sehgal V, Delproposto Z, Haacke EM, Tong KA, Wycliffe N, Kido DK, et al. Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging 2005;22:439-50.  Back to cited text no. 27
[PUBMED]  [FULLTEXT]  
28.Silvera S, Oppenheim C, Touze E, Ducreux D, Page P, Domigo V, et al. Sponteneous intracerebral hematoma on diffusion-weighted images: influence of T2-shine-through and T2-black-out effects. AJNR Am J Neuroradiol 2005;26:236-41.  Back to cited text no. 28
    
29.Murakami R, Sugahara T, Nakamura H, Hirai T, Kitajima M, Hayashida Y, et al. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging. Radiology 2007;243;493-9.  Back to cited text no. 29
    
30.Christy PS, Tervonen O, Scheithauer BW, Forbes GS. Use of a neural network and a multiple regression model to predict histologic grade of astrocytoma from MRI appearances. Neuroradiology 1995;37:89-93.  Back to cited text no. 30
[PUBMED]    
31.Sallinen PK, Sallinen SL, Helen PT, Rantala IS, Rautiainen E, Helin HJ, et al. Grading of diffusely infiltrating astrocytomas by quantitative histopathology, cell proliferation and image cytometric DNA analysis. Comparison of 133 tumours in the context of the WHO 1979 and WHO 1993 grading schemes. Neuropathol Appl Neurobiol 2000;26:319-31.  Back to cited text no. 31
    
32.Belacel N, Boulassel M. Multicriteria fuzzy assignment method: a useful tool to assist medical diagnosis. Artif Intel Med 2001;21:201-7.  Back to cited text no. 32
    
33.Nafe R, Schlote W. Topometric analysis of diffuse astrocytomas. Anal Quant Cytol Histol 2003;25:12-8.  Back to cited text no. 33
[PUBMED]    
34.Flach P, Blockeel H, Ferri C, Hernαndez-Orallo J, Struyf J. Decision support for data mining; An introduction to ROC analysis and its applications. In: Mladeniζ D., Lavrac N., Bohanec M., Moyle S. (Eds.).. Data Mining and Decision. Integration and Collaboration. Boston: Kluwer Publishers; 2003. p. 81-90.  Back to cited text no. 34
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]
 
 
    Tables

  [Table 1], [Table 2]

This article has been cited by
1 Neurosurgery and artificial intelligence
Mohammad Mofatteh
AIMS Neuroscience. 2021; 8(4): 477
[Pubmed] | [DOI]
2 Natural and Artificial Intelligence in Neurosurgery: A Systematic Review
Joeky T. Senders,Omar Arnaout,Aditya V. Karhade,Hormuzdiyar H. Dasenbrock,William B. Gormley,Marike L. Broekman,Timothy R. Smith
Neurosurgery. 2017;
[Pubmed] | [DOI]
3 Phase 3 efficacy and safety trial of gadobutrol, a 1.0 molar macrocyclic MR imaging contrast agent, in patients referred for contrast-enhanced MR imaging of the central nervous system
Juan E. Gutierrez,Martin Rosenberg,Michael Duhaney,Jeffrey A. Simon,Guenther Brueggenwerth,Jacob M. Agris,Edmond A. Knopp
Journal of Magnetic Resonance Imaging. 2014; : n/a
[Pubmed] | [DOI]



 

Top
Print this article  Email this article
Previous article Next article
Online since 20th March '04
Published by Wolters Kluwer - Medknow